Log in to save to my catalogue

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_627f7a95432f4193ae2fb95d8887e02b

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

About this item

Full title

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

Publisher

England: Nature Publishing Group

Journal title

Scientific reports, 2017-05, Vol.7 (1), p.1857-12, Article 1857

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group

More information

Scope and Contents

Contents

Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term treatment with neuroleptics and mostly mediated by dopamine D
2
receptors (D
2
Rs). Striatal D
2
R functioning may be finely regulated by either adenosine A
2A
receptor (A
2A
R) or angiotensin receptor type 1 (AT
1
R) through p...

Alternative Titles

Full title

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_627f7a95432f4193ae2fb95d8887e02b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_627f7a95432f4193ae2fb95d8887e02b

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-017-02037-z

How to access this item